Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.70
+0.05 (0.75%)
Oct 8, 2025, 11:49 AM EDT - Market open
Bioventus Market Cap
Bioventus has a market cap or net worth of $448.18 million as of October 8, 2025. Its market cap has decreased by -41.98% in one year.
Market Cap
448.18M
Enterprise Value
775.93M
1-Year Change
-41.98%
Ranking
Category
Stock Price
$6.70
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $448.18M, a decrease of -37.18%. That is a compound annual growth rate of -9.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 444.83M | -35.19% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | 713.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |